vigeotherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * | ||
Meta Tags
| Title | Home - |
| Description | It’s time to beat Vigeo is a clinical-stage biopharmaceutical company developing novel therapeutics that can effectively treat multiple types of cancer and improve the lives of |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 192.169.220.223 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
vigeotherapeutics.com Valuation
|
US$4,769,580
Last updated: 2023-05-12 02:12:10
vigeotherapeutics.com has Semrush global rank of 2,219,127. vigeotherapeutics.com has an estimated worth of US$ 4,769,580, based on its estimated Ads revenue. vigeotherapeutics.com receives approximately 550,337 unique visitors each day. Its web server is located in United States, with IP address 192.169.220.223. According to SiteAdvisor, vigeotherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,769,580 |
| Daily Ads Revenue | US$4,403 |
| Monthly Ads Revenue | US$132,081 |
| Yearly Ads Revenue | US$1,584,969 |
| Daily Unique Visitors | 36,690 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| vigeotherapeutics.com. | A | 600 | IP: 192.169.220.223 |
| vigeotherapeutics.com. | NS | 3600 | NS Record: ns16.domaincontrol.com. |
| vigeotherapeutics.com. | NS | 3600 | NS Record: ns15.domaincontrol.com. |
| vigeotherapeutics.com. | MX | 3600 | MX Record: 0 vigeotherapeutics-com.mail.protection.outlook.com. |
| vigeotherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-12 02:12:10
| Toggle navigation About Us Overview Our Team Board of Directors Key Advisors Scientific Advisors Our Approach Overview Publications Pipeline News & Media Press Releases In the News Posters & Presentations Careers Contact Us About Us Overview Our Team Board of Directors Key Advisors Scientific Advisors Our Approach Overview Publications Pipeline News & Media Press Releases In the News Posters & Presentations Careers Contact Us It’s time to beat cancer Vigeo is a clinical-stage biopharmaceutical company developing novel therapeutics that can effectively treat multiple types of cancer and improve the lives of patients. Find Out More We are building a first-in-class drug discovery pipeline that reprograms the tumor immune microenvironment (TIME). We believe that by reprogramming the TIME, we can significantly improve cancer treatment outcomes. OUR APPROACH Vigeo is currently developing therapies that target the TIME by activating thrombospondin-1 (Tsp-1), a naturally occurring potent |
vigeotherapeutics.com Whois Information
Domain Name: VIGEOTHERAPEUTICS.COM Registry Domain ID: 1646821440_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-03-18T15:49:34Z Creation Date: 2011-03-22T18:21:37Z Registry Expiry Date: 2022-03-22T18:21:37Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS15.DOMAINCONTROL.COM Name Server: NS16.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-24T07:51:10Z <<< |